Vbi vaccines announces results of annual general meeting

Cambridge, mass.--(business wire)--vbi vaccines inc. (nasdaq: vbiv) ("vbi" or the "company"), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced the voting results from its annual general meeting of shareholders held on june 25, 2024 (the "meeting"). the total number of common shares of the company ("common shares") represented by shareholders ("shareholders") present in person or represented by proxy at the meeting w.
GM Ratings Summary
GM Quant Ranking